Emerging Markets Senior Transaction Advisors
Our team of global advisors provides the experience and insight to guide your pharma, biotech, or med tech transaction through challenging international environments.
Our 500 years of combined experience and diverse backgrounds provide the knowledge and ability to deliver immediate value to your organization at any point throughout the pharma/biotech/med tech M&A, licensing and commercialization spectrum.
Alan Vanderborght, MBA
Chief Executive Officer
20 years of experience in international business development in the pharmaceutical industry. Head of commercial operations and business development for Bristol- Myers Squibb in 16 Latin American countries. Global management consultant. Speaks French and Spanish fluently. Completed nine transactions in global markets in the past three years.
Felix Lara, MBA
Chief Operating Officer
18 years of experience in the Pharmaceutical and MedTech industries. U.S. regional and global leadership positions in Marketing, Business Development and General Management at BMS, Grünenthal, and the Getinge Group . Strong marketing background complemented by extensive experience in complex M&A and Partnership projects in both the U.S. and international settings. As well as general management experience in complex multi-country businesses.
Pauline Salvaing, PharmD
Global Business Development Director
8 years of experience in the pharmaceutical industry in Latam and Europe. Held multiple roles of increasing responsibility and international scope in marketing, API sales, Contract manufacturing and business development at leading global pharmaceutical and life science companies such as Bausch&Lomb, Janssen, and Sanofi.
Dr. Ernesto Neumann, MBA, Ph.D.
Managing Director Latin America
40 + years career with Merck KGaA in Latam. General Manager in Argentina, Brazil, Ecuador, Colombia, Mexico, Peru, and regional VP Latam Merck Serono which had sales of $1.3 B and 2800 employees. During his tenure at Merck, Dr. Neumann realized more than 10 transactions. Merck Serono has the largest sales share in Latam of all multinational companies.
Nicolas Gikakis, MBA
18+ years of experience in the medical device and biotech fields. Global leadership positions at Pall, Terumo, and DSCP/Maquet, managing $200M business. Involved in several distribution, licensing, and M&A deals including the acquisition of brands from J&J, licensing of assets to Medtronic and Terumo, and integration of assets into existing commercial operations. Previous clinical and research background.
Ulrich Steuer, MBA
Managing Director Mexico
30+ years of experience in the pharmaceutical industry in Latam. General Manager for Bristol-Myers Squibb in Mexico and Argentina. Prior to that Ulrich was Vice President Latin America Marketing and Business Development for Aventis where he was responsible for the launch of Lantus® in the region as well as many other products. He also held the position of GM Venezuela for Aventis.
Dr. Khalid M. Alkharfy,Pharm D., Ph.D.
Managing Director Middle East and Africa
12 + years experience in pharmaceutical consultation, management, research, and product development Headed the Research Department of region’s fourth generation science park – Riyadh Techno Valley where he was responsible for managing R&D activities. Managing Director of a biotechnology incubator in Riyadh, Saudi Arabia
Francisco Hidalgo, MBA
Managing Director Latin America
34+ years of experience in the pharmaceutical industry in Latam. General Manager of Brazil, Mexico, Puerto Rico, Caribbean Region, Colombia, Regional VP for Central and South America, and VP of Global Mature Product Portfolio, Geographic Optimization and Footprint, Tactical Divestitures and Distributor Markets Working Group for BMS. VP and COO of Procaps Group.
Rubens Paulella, MBA Thunderbird
Managing Director Brazil
17+ years of experience in the pharmaceutical industry in Latam, mostly in Brazil. Career evolution from Sales Rep to Business Unit Director and Marketing Director (companies such as J&J, Pharmacia&Upjohn, Wyeth, Bristol-Myers Squibb, Mundipharma). Several therapeutic areas expertise. Recent experience as Director of Origination, focused on new opportunities.
Managing Director Med Tech
34+ years of experience in global Med Tech and Pharmaceutical companies, including P&L management, go to market strategy, setting up new operations and building organizations overseas. Founded Procursum Medical in 2015 and former President of International with Hill-Rom; President of the Americas, VP & GM of International Commercial Operations and Regional Director Latin America with Hospira, GM Mexico and Poland with Abbott Laboratories.
Dr. Oye Olukotun,MD, MPH, FACC
30 years experience in the pharma industry. CEO of Epigen Pharma and Vice Chairman of Cardiovax Inc., a biotech company developing innovative cardiovascular therapies. Co-founder and CMO of VIA Pharmaceuticals, CEO of of CR Strategies, LLC, a clinical research and development consulting firm, VP of Regulatory Affairs and CMO of Mallinckrodt, Inc., Director of diaDexus, Inc, past- Director of BioClinica, Nordion, & SemBiosys Genetics Inc.
Dr. Eduardo Rodenas, MD
30+ years experience in the pharma industry building high-performing Medical/Regulatory organizations that support global drug development and business growth. VP of Clinical Operations at The Medicines Company in Europe, Medical Director at Purdue Pharma in the US, and Latina America Regional Director at Bristol-Myers Squibb.
Manfred Stadler, MBA
Managing Director Europe
40+ years of experience in management within multinational corporations,10 of which in the pharmaceutical industry. Assumed roles as CFO and COO of the German and Austrian affiliates of one of the leading international advertising agency networks. Headed the corporate development for Cambrex, where he prepared and executed numerous acquisition processes including post acquisition integration.
International Finance Manager
Extensive finance modeling experience including development of valuations scenarios for companies the rapid infectious disease market. Performed primary and secondary research in the equity market to inform investment decisions. Researched patient engagement trends in healthcare. Worked for Navigant consulting, Pfizer Global Supply Group, and PropThink LLC.